Teprotumumab
Nov 14, 2025
Biologics and The Battle For Sight: How A New Wave of Therapies is Transforming Graves’ Orbitopathy Treatment
From steroid dependence to molecular precision, the Graves’ orbitopathy treatment is undergoing a seismic shift. But can innovation keep pace with the burden of disease? From Desperation to Discovery For decades, Graves’ orbitopathy stood as one of medicine’s most frustrating autoimmune disorders. The c...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
